Original Research

Published on 02 Sep 2022

CRISPR/Cas9-3NLS/sgHMGA2@PDA nanosystem is the potential efficient gene editing therapy for gastric cancer with HMGA2 high expression

in Pharmacology of Anti-Cancer Drugs

Zhouying Wu
Xue Huo
Tingyu Yang
Kun Liu
Ting Wu
Zongqi Feng
Min Wang
Feng Li
Jianchao Jia
Xiaoran Zhang

Frontiers in Oncology

doi 10.3389/fonc.2022.978533

2,857 views
3 citations

Original Research

Published on 30 Aug 2022

Tumor-infiltrating immune cells based TMEscore and related gene signature is associated with the survival of CRC patients and response to fluoropyrimidine-based chemotherapy

in Pharmacology of Anti-Cancer Drugs

Xian-Wen Guo
Si-Qi Li
Rong-E Lei
Zhen Ding
Bang-li Hu
Rong Lin

Frontiers in Oncology

doi 10.3389/fonc.2022.953321

2,038 views
2 citations

Systematic Review

Published on 29 Aug 2022

Integration of healthy volunteers in early phase clinical trials with immuno-oncological compounds

in Pharmacology of Anti-Cancer Drugs

Igor Radanovic
Naomi Klarenbeek
Robert Rissmann
Geert Jan Groeneveld
Emilie M. J. van Brummelen
Matthijs Moerland
Jacobus J. Bosch

Frontiers in Oncology

doi 10.3389/fonc.2022.954806

6,019 views
1 citation

Original Research

Published on 29 Aug 2022

Effect of glycated hemoglobin A1c on the survival of patients with oral squamous cell carcinoma: A multi-institutional database cohort study

in Pharmacology of Anti-Cancer Drugs

Chun-Yuan Chao
Sheng-Dean Luo
Wei-Chih Chen
Shao-Chun Wu
Tai-Jan Chiu
Yu-Ming Wang
Yao-Hsu Yang
Fu-Min Fang
Shau-Hsuan Li
Chung-Yi Li

Frontiers in Oncology

doi 10.3389/fonc.2022.952616

2,387 views
4 citations

Review

Published on 24 Aug 2022

Clinical applications of circulating tumor cells in hepatocellular carcinoma

in Pharmacology of Anti-Cancer Drugs

Yinggang Hua
Jingqing Dong
Jinsong Hong
Bailin Wang
Yong Yan
Zhiming Li

Frontiers in Oncology

doi 10.3389/fonc.2022.968591

2,943 views
7 citations

Original Research

Published on 18 Aug 2022

In vitro elucidation of antioxidant, antiproliferative, and apoptotic potential of yeast-derived β-1,3-glucan particles against cervical cancer cells

in Pharmacology of Anti-Cancer Drugs

Tarun Kumar Upadhyay
Rashmi Trivedi
Fahad Khan
Lamya Ahmed Al-Keridis
Pratibha Pandey
Amit Baran Sharangi
Nawaf Alshammari
Nadiya M. Abdullah
Dharmendra Kumar Yadav
Mohd Saeed

Frontiers in Oncology

doi 10.3389/fonc.2022.942075

3,459 views
11 citations

Review

Published on 17 Aug 2022

Angiogenesis in NENs, with a focus on gastroenteropancreatic NENs: from biology to current and future therapeutic implications

in Pharmacology of Anti-Cancer Drugs

Eleonora Lauricella
Barbara Mandriani
Federica Cavallo
Gaetano Pezzicoli
Nada Chaoul
Camillo Porta
Mauro Cives

Frontiers in Oncology

doi 10.3389/fonc.2022.957068

3,336 views
4 citations

Original Research

Published on 17 Aug 2022

BTN3A3 inhibits the proliferation, migration and invasion of ovarian cancer cells by regulating ERK1/2 phosphorylation

in Pharmacology of Anti-Cancer Drugs

Sihan Chen
Zhangyun Li
Yanyan Wang
Shaohua Fan

Frontiers in Oncology

doi 10.3389/fonc.2022.952425

2,601 views
8 citations

Original Research

Published on 17 Aug 2022

Ginseng-derived nanoparticles inhibit lung cancer cell epithelial mesenchymal transition by repressing pentose phosphate pathway activity

in Pharmacology of Anti-Cancer Drugs

Lan Yang
Wen-qi Jin
Xiao-lei Tang
Shuai Zhang
Rui Ma
Da-qing Zhao
Li-wei Sun

Frontiers in Oncology

doi 10.3389/fonc.2022.942020

3,413 views
8 citations

Review

Published on 17 Aug 2022

Targeting O-GlcNAcylation to overcome resistance to anti-cancer therapies

in Pharmacology of Anti-Cancer Drugs

Ninon Very
Ikram El Yazidi-Belkoura

Frontiers in Oncology

doi 10.3389/fonc.2022.960312

3,931 views
7 citations

Review

Published on 17 Aug 2022

Non-coding RNA in cancer drug resistance: Underlying mechanisms and clinical applications

in Pharmacology of Anti-Cancer Drugs

Xuehao Zhou
Xiang Ao
Zhaojun Jia
Yiwen Li
Shouxiang Kuang
Chengcheng Du
Jinyu Zhang
Jianxun Wang
Ying Liu

Frontiers in Oncology

doi 10.3389/fonc.2022.951864

5,817 views
72 citations

Original Research

Published on 16 Aug 2022

Combinatorial delivery of CPI444 and vatalanib loaded on PEGylated graphene oxide as an effective nanoformulation to target glioblastoma multiforme: In vitro evaluation

in Pharmacology of Anti-Cancer Drugs

Vishnu S. Mishra
Sachin Patil
Puli Chandramouli Reddy
Bimlesh Lochab

Frontiers in Oncology

doi 10.3389/fonc.2022.953098

2,658 views
8 citations

Original Research

Published on 15 Aug 2022

Axillary management for early invasive breast cancer patients: Who will truly benefit?

in Pharmacology of Anti-Cancer Drugs

Yanbiao Liu
Yan Fan
Zining Jin
Mengyao Cui
Xinmiao Yu
Feng Jin
Xu Wang

Frontiers in Oncology

doi 10.3389/fonc.2022.989975

2,230 views
4 citations

Correction

Published on 12 Aug 2022

Corrigendum: Cucurbitacin B, purified and characterized from the rhizome of Corallocarpus epigaeus exhibits anti-melanoma potential

in Pharmacology of Anti-Cancer Drugs

Sreekumar Usha Devi Aiswarya
Gowda Vikas
Nair Hariprasad Haritha
Vijayasteltar Belsamma Liju
Anwar Shabna
Mundanattu Swetha
Tennyson Prakash Rayginia
Chenicheri Kizhakkeveettil Keerthana
Lekshmi Raghu Nath
Mullan Vellandy Reshma

Frontiers in Oncology

doi 10.3389/fonc.2022.989283

1,309 views
2 citations

Review

Published on 11 Aug 2022

Frontiers of ferroptosis research: An analysis from the top 100 most influential articles in the field

in Pharmacology of Anti-Cancer Drugs

Kunming Cheng
Qiang Guo
Zefeng Shen
Weiguang Yang
Yan Zhou
Zaijie Sun
Xiuhua Yao
Haiyang Wu

Frontiers in Oncology

doi 10.3389/fonc.2022.948389

9,972 views
23 citations

Original Research

Published on 10 Aug 2022

Mechanistic insights into the clinical Y96D mutation with acquired resistance to AMG510 in the KRASG12C

in Pharmacology of Anti-Cancer Drugs

Haiming Zhuang
Jigang Fan
Mingyu Li
Hao Zhang
Xiuyan Yang
Ligen Lin
Shaoyong Lu
Qing Wang
Yaqin Liu

Frontiers in Oncology

doi 10.3389/fonc.2022.915512

3,143 views
8 citations

Navigation group

Articles

CRISPR/Cas9-3NLS/sgHMGA2@PDA nanosystem is the potential efficient gene editing therapy for gastric cancer with HMGA2 high expression

Tumor-infiltrating immune cells based TMEscore and related gene signature is associated with the survival of CRC patients and response to fluoropyrimidine-based chemotherapy

Integration of healthy volunteers in early phase clinical trials with immuno-oncological compounds

Effect of glycated hemoglobin A1c on the survival of patients with oral squamous cell carcinoma: A multi-institutional database cohort study

Clinical applications of circulating tumor cells in hepatocellular carcinoma

In vitro elucidation of antioxidant, antiproliferative, and apoptotic potential of yeast-derived β-1,3-glucan particles against cervical cancer cells

Angiogenesis in NENs, with a focus on gastroenteropancreatic NENs: from biology to current and future therapeutic implications

BTN3A3 inhibits the proliferation, migration and invasion of ovarian cancer cells by regulating ERK1/2 phosphorylation

Ginseng-derived nanoparticles inhibit lung cancer cell epithelial mesenchymal transition by repressing pentose phosphate pathway activity

Targeting O-GlcNAcylation to overcome resistance to anti-cancer therapies

Non-coding RNA in cancer drug resistance: Underlying mechanisms and clinical applications

Combinatorial delivery of CPI444 and vatalanib loaded on PEGylated graphene oxide as an effective nanoformulation to target glioblastoma multiforme: In vitro evaluation

Axillary management for early invasive breast cancer patients: Who will truly benefit?

Corrigendum: Cucurbitacin B, purified and characterized from the rhizome of Corallocarpus epigaeus exhibits anti-melanoma potential

Frontiers of ferroptosis research: An analysis from the top 100 most influential articles in the field

Mechanistic insights into the clinical Y96D mutation with acquired resistance to AMG510 in the KRASG12C